Adalimumab, etanercept and infliximab for ankylosing spondylitis
National Institute for Health and Clinical Excellence
Record Status
This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database.
Citation
National Institute for Health and Clinical Excellence. Adalimumab, etanercept and infliximab for ankylosing spondylitis. London: National Institute for Health and Clinical Excellence (NICE). Technology Appraisal Guidance 143. 2008
National Institute for Health and Clinical Excellence, MidCity Place, 71 High Holborn, London WC1V 6NA, UK Tel: +44 020 7067 5800; Fax: +44 020 7067 5801 Email: nice@nice.nhs.uk